222 related articles for article (PubMed ID: 9886237)
1. Colonic drug targeting.
Kinget R; Kalala W; Vervoort L; van den Mooter G
J Drug Target; 1998; 6(2):129-49. PubMed ID: 9886237
[TBL] [Abstract][Full Text] [Related]
2. Colonic drug delivery: an updated review.
Shareef MA; Khar RK; Ahuja A; Ahmad FJ; Raghava S
AAPS PharmSci; 2003; 5(2):E17. PubMed ID: 12866944
[TBL] [Abstract][Full Text] [Related]
3. Colon drug delivery.
Van den Mooter G
Expert Opin Drug Deliv; 2006 Jan; 3(1):111-25. PubMed ID: 16370944
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
5. [Site-specific drug delivery systems. I. Colon targeted delivery].
Szente V; Zelkó R
Acta Pharm Hung; 2007; 77(3):185-9. PubMed ID: 18019784
[TBL] [Abstract][Full Text] [Related]
6. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
Asghar LF; Chandran S
J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
[TBL] [Abstract][Full Text] [Related]
7. [New systems for colonic drug targeting].
Janovská L; Vetchý D; Rabisková M
Ceska Slov Farm; 2006 Sep; 55(5):203-9. PubMed ID: 17128589
[TBL] [Abstract][Full Text] [Related]
8. [Biodegradable polymers for colon-specific drug delivery].
Musiał W; Kubis A
Polim Med; 2005; 35(4):51-61. PubMed ID: 16619797
[TBL] [Abstract][Full Text] [Related]
9. Oral colon delivery: rationale and time-based drug design strategy.
Gazzaniga A; Maroni A; Foppoli A; Palugan L
Discov Med; 2006 Dec; 6(36):223-8. PubMed ID: 17250787
[TBL] [Abstract][Full Text] [Related]
10. Colonic treatments and targets: issues and opportunities.
McConnell EL; Liu F; Basit AW
J Drug Target; 2009 Jun; 17(5):335-63. PubMed ID: 19555265
[TBL] [Abstract][Full Text] [Related]
11. Polysaccharides: a targeting strategy for colonic drug delivery.
Shah N; Shah T; Amin A
Expert Opin Drug Deliv; 2011 Jun; 8(6):779-96. PubMed ID: 21506904
[TBL] [Abstract][Full Text] [Related]
12. Targeting drugs to the colon: delivery systems for oral administration.
Ashford M; Fell JT
J Drug Target; 1994; 2(3):241-57. PubMed ID: 7812693
[TBL] [Abstract][Full Text] [Related]
13. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
Ali Asghar LF; Azeemuddin M; Jain V; Chandran S
Drug Deliv; 2009 Aug; 16(6):295-303. PubMed ID: 19606943
[TBL] [Abstract][Full Text] [Related]
14. Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract.
Fell JT
J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):517-9. PubMed ID: 8982825
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
Goto T; Tanida N; Yoshinaga T; Sato S; Ball DJ; Wilding IR; Kobayashi E; Fujimura A
J Control Release; 2004 May; 97(1):31-42. PubMed ID: 15147802
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
Asghar LF; Azeemuddin M; Jain V; Chandran S
Drug Deliv; 2009 May; 16(4):205-13. PubMed ID: 19514981
[TBL] [Abstract][Full Text] [Related]
17. What should be considered on design of a colon-specific prodrug?
Jung Y; Kim YM
Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
[TBL] [Abstract][Full Text] [Related]
18. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.
Krishnaiah YS; Khan MA
Pharm Dev Technol; 2012; 17(5):521-40. PubMed ID: 22681390
[TBL] [Abstract][Full Text] [Related]
19. Design of pH-sensitive microspheres for the colonic delivery of the immunosuppressive drug tacrolimus.
Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
Eur J Pharm Biopharm; 2004 Jul; 58(1):37-43. PubMed ID: 15207535
[TBL] [Abstract][Full Text] [Related]
20. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.
Chuong MC; Christensen JM; Ayres JW
Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
